These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7703282)

  • 61. Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
    Silvennoinen R; Kairisto V; Pelliniemi TT; Putkonen M; Anttila P; Säily M; Sikiö A; Opas J; Penttilä K; Kuittinen T; Honkanen T; Lundán T; Juvonen V; Luukkaala T; Remes K
    Br J Haematol; 2013 Feb; 160(4):561-4. PubMed ID: 23206270
    [No Abstract]   [Full Text] [Related]  

  • 62. Hepatitis B resolution after autologous Bone Marrow Transplantation.
    Ozturk O; Koklu S; Aksoy EK
    Acta Gastroenterol Belg; 2015 Jun; 78(2):255. PubMed ID: 26151702
    [No Abstract]   [Full Text] [Related]  

  • 63. Multiple myeloma.
    Spitzer TR; Sachs DH; Cosimi B
    N Engl J Med; 2011 Jun; 364(24):2364; author reply 2364. PubMed ID: 21675904
    [No Abstract]   [Full Text] [Related]  

  • 64. Gene therapy approaches for multiple myeloma.
    Russell SJ; Dunbar CE
    Semin Hematol; 2001 Jul; 38(3):268-75. PubMed ID: 11486315
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hematopoietic stem cell gene replacement therapy.
    Krauss JC
    Biochim Biophys Acta; 1992 Dec; 1114(2-3):193-207. PubMed ID: 1360816
    [No Abstract]   [Full Text] [Related]  

  • 66. Modern trends in the treatment of multiple myeloma.
    Dicke KA
    Curr Opin Oncol; 1990 Apr; 2(2):277-84. PubMed ID: 2095242
    [No Abstract]   [Full Text] [Related]  

  • 67. Gene therapy for multiple myeloma.
    Adachi Y; Yoshio-Hoshino N; Nishimoto N
    Curr Gene Ther; 2008 Aug; 8(4):247-55. PubMed ID: 18691020
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells.
    Keating A; Berkahn L; Filshie R
    Hum Gene Ther; 1998 Mar; 9(4):591-600. PubMed ID: 9525320
    [No Abstract]   [Full Text] [Related]  

  • 69. Potential applications of gene therapy.
    Kohn DB; Kantoff PW
    Transfusion; 1989; 29(9):812-20. PubMed ID: 2686109
    [No Abstract]   [Full Text] [Related]  

  • 70. Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.
    Deisseroth AB; Kavanagh J; Champlin R
    Hum Gene Ther; 1994 Dec; 5(12):1507-22. PubMed ID: 7711143
    [No Abstract]   [Full Text] [Related]  

  • 71. Multiple myeloma.
    Russel NH; Hunter AE; Haynes A; Bessell EM
    BMJ; 1994 Jun; 308(6945):1715. PubMed ID: 8068129
    [No Abstract]   [Full Text] [Related]  

  • 72. Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response.
    Lotze MT; Rubin JT; Carty S; Edington H; Ferson P; Landreneau R; Pippin B; Posner M; Rosenfelder D; Watson C
    Hum Gene Ther; 1994 Jan; 5(1):41-55. PubMed ID: 8155771
    [No Abstract]   [Full Text] [Related]  

  • 73. Bone marrow transplantation in multiple myeloma: current status and future perspectives.
    Tura S
    Bone Marrow Transplant; 1986 May; 1(1):17-20. PubMed ID: 3332115
    [No Abstract]   [Full Text] [Related]  

  • 74. Graft-versus-myeloma effect.
    Aschan J; Lönnqvist B; Ringdén O; Kumlien G; Gahrton G
    Lancet; 1996 Aug; 348(9023):346. PubMed ID: 8709723
    [No Abstract]   [Full Text] [Related]  

  • 75. Bone marrow transplantation in multiple melanoma.
    Gahrton G; Ringdén O; Lönnqvist B
    Acta Med Scand; 1986; 219(5):433-4. PubMed ID: 3526818
    [No Abstract]   [Full Text] [Related]  

  • 76. Use a gentle approach for refractory myeloma patients.
    Bergsagel DE
    J Clin Oncol; 1988 May; 6(5):757-8. PubMed ID: 3284972
    [No Abstract]   [Full Text] [Related]  

  • 77. Immuno-gene therapy for myeloma using cytokines.
    Paillard F
    Hum Gene Ther; 1998 Jan; 9(1):1-2. PubMed ID: 9458235
    [No Abstract]   [Full Text] [Related]  

  • 78. Gene-marking studies in bone marrow may yield treatments.
    Jenks S
    J Natl Cancer Inst; 1993 Nov; 85(22):1799-800. PubMed ID: 8230257
    [No Abstract]   [Full Text] [Related]  

  • 79. Randomized phase 2 study of digital life coaching during transplantation for myeloma.
    Banerjee R; Huang CY; Ryan C; Lee A; Brassil KJ; Moore J; Arora S; Chung A; Wong SW; Wolf J; Martin T; Dhruva A; Shah N
    Bone Marrow Transplant; 2023 Dec; 58(12):1406-1409. PubMed ID: 37743374
    [No Abstract]   [Full Text] [Related]  

  • 80. Future prospects for the therapy of multiple myeloma.
    Case DC
    Cancer Invest; 1989; 7(3):243-6. PubMed ID: 2676089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.